Shortage of antibiotics and glaucoma drugs in Alicante

The supply of Ozempic has started to get back to normal in the last few weeks, although there are still a lot of drug shortages in Alicante and all throughout the country. The Spanish Agency for Medicines and Health Products (AEMPS) says that around 1,000 medications are now having trouble getting enough of them. This is a long-term problem that affects therapies for chronic illnesses more than others. Just because some well-known drugs are easier to get doesn’t mean the problem is over.

The data shows that the number of shortages reported by pharmacies has gone down over the past month for diabetic medicines. This means that supply is getting better. Ozempic is no longer the drug that has the biggest supply concerns in this situation.

Advertisements

Long-term diseases

This group is becoming better, but others are getting worse. There are more and more shortages of treatments for long-term illnesses, including depression and epilepsy. The current supply issues primarily affect these individuals.

As Christmas gets closer, which medicines are the toughest to find in Alicante pharmacies? Luda Partners, a digital pharmacy network that helps consumers find pharmaceuticals that are out of supply right away, says that antibiotics are one of the classes that is most affected right now. Recently, the internet network has found 11% of prescriptions to be antibacterial. One of them, which is used to treat urinary tract infections, is intriguing.

Enzymes

Second, therapies for glaucoma currently account for about 6% of the available treatments. The next category includes medications for individuals with pancreatic insufficiency, which account for approximately 5% of all available products. Kreon is now one of the hardest medicines to get.

Colircusi, for eye issues; Stilnox, for sleeplessness; and Gabapentin, for peripheral neuropathic pain, like that produced by shingles, are some of the medications that are most affected, along with the ones already listed.

In all of Europe

This isn’t just happening in Spain. Health officials are worried because other European countries are also having trouble getting drugs, especially for long-term and necessary treatments. It is a common problem that tests how well European healthcare systems can respond, both in each country and at the EU level, and needs a coordinated response.

Experts agree that this problem is due to deep-rooted issues that are hard to fix quickly, such as moving a lot of production outside the European Union and ongoing problems in global shipping.

There are also things like higher demand, pricing changes, and some regulatory issues that make things worse. In this situation, Europe needs to work on making its medications more strategically independent, enhancing its planning, and using technology to help lessen the effects of shortages on patients’ daily lives.

Author: Derek Appleton